ONCY,Oncolytics Biotech Inc. | Healthcare

Healthcare

ONCY

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Oncolytics Biotech Inc.ONCY

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer.

The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma.

Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and Bavencio, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer.

The company was incorporated in 1998 and is headquartered in Calgary, Canada.

Latest News >

Coterra Energy Q1 Adjusted Earnings, Revenue Rise

May 26, 2025

05:20 PM EDT, 05/05/2025 (MT Newswires) -- Coterra Energy ( CTRA ) reported Q1 adjusted earnings late Monday of $0.80 per diluted share, up from $0.51 a year earlier. Analysts surveyed by FactSet expected $0.81. Revenue for the quarter ended March 31 was $1.90 billion, up from $1.43 billion a year earlier. Analysts polled by FactSet expected $1.99 billion. The...

Diamondback Energy Reports Better-Than-Expected Q1: Details

May 26, 2025

Diamondback Energy, Inc. ( FANG ) released its first-quarter results after Monday's closing bell. Here's a look at the details from the report. The Details: Diamondback Energy reported adjusted earnings of $4.54 per share, which beat the analyst consensus estimate of $4.13. Quarterly revenue clocked in at $4.05 billion, beating the $3.73 billion consensus estimate. Read Next:Saudi Arabia’s Oil Power Play Jolts Markets:...

Cargurus Insider Sold Shares Worth $1,888,294, According to a Recent SEC Filing

May 26, 2025

05:18 PM EDT, 05/05/2025 (MT Newswires) -- Langley Steinert, 10% Owner, Director, Executive Chair, on May 01, 2025, sold 67,043 shares in Cargurus ( CARG ) for $1,888,294. Following the Form 4 filing with the SEC, Steinert has control over a total of 827,385 Class A common shares of the company, with 794,185 shares held directly and 33,200 controlled indirectly....

Paymentus Q1 Non-GAAP EPS, Revenue Rise, Sets Outlooks

May 26, 2025

05:21 PM EDT, 05/05/2025 (MT Newswires) -- Paymentus Holdings ( PAY ) reported Q1 non-GAAP net income late Monday of $0.14 per diluted share, up from $0.09 a year ago. Analysts polled by FactSet expected $0.13. Revenue for the quarter ended March 31 was $275.2 million, up from $184.9 million a year earlier. Analysts expected $251 million. For Q2, the...